Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Phase 1 Unknown
71 enrolled
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
Phase 1/2 Unknown
110 enrolled
Detection of Cancer in Breath Samples by Trained Detection Dogs
Unknown
1,250 enrolled
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
Phase 1 Unknown
12 enrolled
URODETECT-WP1
Phase NA Unknown
105 enrolled
MDPK67b in Patients With Prostate Cancer
Phase 1 Unknown
15 enrolled
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.
Phase 1/2 Unknown
24 enrolled
Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel⢠Platform
Unknown
2,019 enrolled
Evaluation of the Sentinel⢠PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico
Unknown
500 enrolled
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer
Phase 3 Unknown
267 enrolled
Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer
Phase 1 Unknown
9 enrolled
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
Unknown
230 enrolled
Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
Phase 1 Unknown
108 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With ZoladexĀ® 10.8mg
Phase 1 Unknown
24 enrolled
CADENCE
Unknown
15,000 enrolled
WEE1
Phase 1 Unknown
350 enrolled
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
Phase NA Unknown
6 enrolled
MyProstateScore Equivalency With and Without DRE
Phase NA Unknown
800 enrolled
RESTORE
Phase NA Unknown
352 enrolled
ExoDx Prostate Evaluation in Active Surveillance Patient Population
Unknown
750 enrolled
Decision Impact Trial of the ExoDx Prostate (IntelliScore)
Phase NA Unknown
1,000 enrolled
A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening
Unknown
200 enrolled
Assessment of VMCore Biopsy Versus Standard of Care Biopsy
Phase NA Unknown
40 enrolled
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
Phase 1 Unknown
40 enrolled
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
Phase 3 Unknown
654 enrolled
PIONEER
Unknown
1,000 enrolled
LPM-012
Phase NA Unknown
56 enrolled
A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
Phase 1/2 Unknown
197 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γΓ T Cells for Relapsed or Refractory Solid Tumour
Phase 1 Unknown
10 enrolled
Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the SonablateĀ® 500 System in Canada
Phase NA Unknown
20 enrolled
SetPace
Phase NA Unknown
466 enrolled
STAR
Phase NA Unknown
117 enrolled
ClariCore⢠Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy
Phase NA Unknown
100 enrolled
ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy
Phase NA Unknown
200 enrolled
SCORE
Phase NA Unknown
325 enrolled
PERSEE II
Phase NA Unknown
100 enrolled
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Phase 1 Unknown
95 enrolled
Comparison of a Novel Leuprolide With Market Leuprolide
Phase NA Unknown
48 enrolled
PRIORITY
Unknown
1,000 enrolled
FOC/DYN
Phase NA Unknown
180 enrolled
ProRAFT
Phase NA Unknown
20 enrolled
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
Unknown
500 enrolled
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Phase 1 Unknown
69 enrolled
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer
Phase 1/2 Unknown
24 enrolled
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
Unknown
5,000 enrolled
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device
Phase NA Unknown
30 enrolled
Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer
Phase 1 Unknown
44 enrolled